Reactions 1704, p56 - 2 Jun 2018 X S Rhabdomyolysis: case report A 51-year-old man developed severe rhabdomyolysis following concomitant administration of fusidic acid for an osteitis and atorvastatin. The man, who was on multiple medications including systemic fusidic acid 500mg three times a day [route not stated] for an osteitis and atorvastatin 80mg once a day [route and indication not stated], experienced leg pain a week after undergoing a stress test and 33 days post the initiation of antibiotic therapy. Fusidic acid was withdrawn. The man was unable to walk due to muscle weakness and myalgia, and he was hospitalised. During hospitalisation, he experienced anuria and exhibited significantly elevated levels of serum creatinine, serum creatine kinase, myoglobin and AST. On the third day of hospitalisation, atorvastatin was suspended. His condition improved after 9 days of hospitalisation and dialysis; however, a sequelar amyotrophy of his thighs was observed. He was discharged without statin treatment. Author comment: "Following a severe case of rhabdomyolysis . . . after a co-administration of atorvastatin and fusidic acid, we describe this interaction". Deljehier T, et al. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions. British Journal of Clinical Pharmacology 84: 1057-1063, No. 5, May 2018. Available from: URL: http://doi.org/10.1111/bcp.13515 - France 803323505 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera